Grant: Doctoral Research Award: Canada Graduate Scholarships
Université Laval
$105,000.00
New Risk-Stratification Tools in Organic Mitral Regurgitation: Best Approach for An Enlightened Clinical Decision-Making Process
FY 2020-21
Summary
The mitral valve is a cardiac valve that ensures the right direction of the blood flow. Sometimes this valve is leaking (blood goes back in the wrong way) because the valve is distorted, this is Organic Mitral Regurgitation (OMR). When severe, this disease has serious consequences on the cardiac function. OMR is one of the most prevalent valvular heart diseases and it is associated with high rates of mortality. The only treatments are to repair or replace the valve surgically. When symptoms occur, patients must undergo surgery right away. Before the onset of symptoms, sending patients to surgery for OMR is controversial: physicians must balance the risk of surgery versus the risk of irrecoverable damage to the heart. Unfortunately, markers of heart damage are scarce and often lead towards sequels after intervention. Moreover, most triggers for surgery are not defined according to the sex of the patient (women have smaller cavities). The objective of this project is to develop and validate novel sex-specific imaging and blood markers to improve risk stratification and therapeutic decision-making process in asymptomatic patients with
OMR. To achieve this objective, patients with OMR are recruited in the prospective PROGRAM study (NCT01835054; CIHR funded). These patients are followed 10 years and each year they undergo several clinical exams (i.e. echocardiography) in order to find good predictive parameters. There are currently over 195 participants and recruitment is still ongoing (objective of 330). This doctoral project will contribute to 1) obtain a better representation of the impact of valve leaking on the functional ability of these patients, 2) establish a better risk stratification, and 3) discriminate the patients who benefit from early ''prophylactic'' surgery from those who can wait without risk before surgery. Finally, differences between men and women in the pathophysiology, diagnosis, management, and treatment of OMR will be investigated by this study.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
439441
Name
Bernard Jérémy
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
New Risk-Stratification Tools in Organic Mitral Regurgitation: Best Approach for An Enlightened Clinical Decision-Making Process
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Ambulatory Electrocardiogram Monitoring; Biomarkers; Cardiac Magnetic Resonance; Disease Progression; Doppler-Echocardiography; Heart Failure; Mitral Valve Surgery; Organic Mitral Regurgitation; Risk Stratification; Sex-Differences
Abstract
The mitral valve is a cardiac valve that ensures the right direction of the blood flow. Sometimes this valve is leaking (blood goes back in the wrong way) because the valve is distorted, this is Organic Mitral Regurgitation (OMR). When severe, this disease has serious consequences on the cardiac function. OMR is one of the most prevalent valvular heart diseases and it is associated with high rates of mortality. The only treatments are to repair or replace the valve surgically. When symptoms occur, patients must undergo surgery right away. Before the onset of symptoms, sending patients to surgery for OMR is controversial: physicians must balance the risk of surgery versus the risk of irrecoverable damage to the heart. Unfortunately, markers of heart damage are scarce and often lead towards sequels after intervention. Moreover, most triggers for surgery are not defined according to the sex of the patient (women have smaller cavities). The objective of this project is to develop and validate novel sex-specific imaging and blood markers to improve risk stratification and therapeutic decision-making process in asymptomatic patients with
OMR. To achieve this objective, patients with OMR are recruited in the prospective PROGRAM study (NCT01835054; CIHR funded). These patients are followed 10 years and each year they undergo several clinical exams (i.e. echocardiography) in order to find good predictive parameters. There are currently over 195 participants and recruitment is still ongoing (objective of 330). This doctoral project will contribute to 1) obtain a better representation of the impact of valve leaking on the functional ability of these patients, 2) establish a better risk stratification, and 3) discriminate the patients who benefit from early ''prophylactic'' surgery from those who can wait without risk before surgery. Finally, differences between men and women in the pathophysiology, diagnosis, management, and treatment of OMR will be investigated by this study.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bernard, Jérémy
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~